Author

Jean-Frederic Colombel 1

1 Icahn School of Medicine at Mount Sinai

A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EXPLORE THE EFFICACY OF ORAL GED-0301 (MONGERSEN) ON ENDOSCOPIC ACTIVITY AND CLINICAL EFFECTS IN BOTH TNF-NAIVE AND TNF-EXPERIENCED SUBJECTS WITH ACTIVE CROHN?S DISEASE

Brian G. Feagan, Bruce E. Sands, Guillermo Rossiter, Xiaobin Li, Keith Usiskin, Xiaojiang Zhan, Jean-Frederic Colombel

AbbVie - Are we ready to change the course of IBD?

Edouard Louis, Remo Panaccione, Laurent Peyrin-Biroulet, Jean-Frederic Colombel

Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

Jean François Rahier, Fernando Jose Magro Dias, C Abreu, Alessandro Armuzzi, Shomron Ben-Horin, Yehuda Chowers, Mario Cottone, Lissy de Ridder, Glen A Doherty, Robert Ehehalt, Maria Esteve Comas, Konstantinos H. Katsanos, Charlie Lees, E MacMahon, Tom Moreels, Walter Reinisch, Herbert Tilg, L Tremblay, Gigi Veereman, N V

COMPOSITE REMISSION MEASURES IN EARLY CROHN’S DISEASE: A POST-HOC ANALYSIS OF THE SONIC TRIAL

Walter Reinisch, Gerassimos J. Mantzaris, Asher Kornbluth, A Oortwijn, G S Bevelander, Freddy Cornillie, Jean-Frederic Colombel, William Sandborn

CORRELATION OF BIOMARKERS OF INFLAMMATION WITH CLINICAL AND ENDOSCOPIC ENDPOINTS IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE: DATA FROM CELEST

Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Silvio Danese, Simon Travis, Gerald Dryden, Robert Hardi, Michael S Epstein, Wen Zhou, Fabio Cataldi, Bidan Huang, Ana Paula Lacerda, Julian Panés

CORRELATION OF BIOMARKERS OF INFLAMMATION WITH CLINICAL AND ENDOSCOPIC ENDPOINTS IN PATIENTS WITH MODERATE-TO-SEVERE CROHN’S DISEASE: DATA FROM CELEST

Jean-Frederic Colombel

CALPROTECTIN IS LESS ACCURATE THAN MAYO ENDOSCOPY SCORE TO MONITOR CONTINUOUS CLINICAL RESPONSE IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS

Walter Reinisch, Jean-Frederic Colombel, Ahmed Khalifa, Ruji Yao, Susan Huyck, George Philip, Freddy Cornillie

Association of Ustekinumab Serum Concentrations and Perianal Fistula Resolution in the Crohn's Disease UNITI Program

Bruce E. Sands, Brian Kramer, Christopher Gasink, Douglas Jacobstein, Long-Long Gao, Tony Ma, Omoniyi J. Adedokun, Jean-Frederic Colombel, David A Schwartz

CHARACTERIZATION OF MUCOSAL HEALING WITH ADALIMUMAB TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE FROM EXTEND

Walter Reinisch, Jean-Frederic Colombel, Geert R. D'Haens, William Sandborn, Paul Rutgeerts, Joel Petersson, Samantha Eichner, Annalisa Iezzi, Roopal B Thakkar

CLINICAL BENEFIT OF ADALIMUMAB DOSE ADJUSTMENT FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE IN EXTEND

Jean-Frederic Colombel, Paul Rutgeerts, William Sandborn, Douglas C. Wolf, Walter Reinisch, Gert Van Assche, Samantha Eichner, Joel Petersson, Anne M. Robinson, Roopal B Thakkar

Item 1 - 10 / 80
1
2 3 4 5 6 7 8